RU94020847A - Tranquilizing agent - Google Patents

Tranquilizing agent

Info

Publication number
RU94020847A
RU94020847A RU94020847/14A RU94020847A RU94020847A RU 94020847 A RU94020847 A RU 94020847A RU 94020847/14 A RU94020847/14 A RU 94020847/14A RU 94020847 A RU94020847 A RU 94020847A RU 94020847 A RU94020847 A RU 94020847A
Authority
RU
Russia
Prior art keywords
tea
dose
motherwort
soluble
recommended
Prior art date
Application number
RU94020847/14A
Other languages
Russian (ru)
Inventor
В.Г. Кукес
А.А. Карпеев
Т.Л. Киселева
Л.А. Павлова
В.К. Колхир
В.П. Бойко
М.Ф. Минеева
Н.Г. Оленина
Original Assignee
Научно-исследовательский институт традиционных методов лечения
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-исследовательский институт традиционных методов лечения filed Critical Научно-исследовательский институт традиционных методов лечения
Priority to RU94020847/14A priority Critical patent/RU94020847A/en
Publication of RU94020847A publication Critical patent/RU94020847A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

FIELD: pharmacy. SUBSTANCE: invention proposes the use of soluble "tea" prepared of motherwort as a tranquilizing agent. Soluble motherwort "tea" shows exciting action at dose 100 mg/kg (in mice) and at dose 500-1000 mg/kg can be recommended as weak tranquilizing agent. For human dose is 1 tea-spoon per one-half water glass, 2-3 times per a day, before eating. EFFECT: enhanced effectiveness.

Claims (1)

Изобретение относится к области медицины и касается использования лекарственных растений в медицинской практике. Сущность изобретения заключается в использовании растворимого чая пустырника в качестве транквилизирующего средства. Растворимый чай пустырника (установлено экспериментально на мышах) в дозе 100 мг/кг проявляет возбуждающее действие, а в дозе 500-1000 мг/кг может быть рекомендован в качестве слабого транквилизатора. Для человека рекомендуется на прием по 1 чайной ложке на полстакана воды 2 - 3 раза в день до еды.The invention relates to medicine and relates to the use of medicinal plants in medical practice. The essence of the invention lies in the use of soluble motherwort tea as a tranquilizing agent. Soluble motherwort tea (established experimentally in mice) at a dose of 100 mg / kg exhibits an exciting effect, and at a dose of 500-1000 mg / kg can be recommended as a weak tranquilizer. For a person, it is recommended to take 1 teaspoon in half a glass of water 2 to 3 times a day before meals.
RU94020847/14A 1994-06-06 1994-06-06 Tranquilizing agent RU94020847A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94020847/14A RU94020847A (en) 1994-06-06 1994-06-06 Tranquilizing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94020847/14A RU94020847A (en) 1994-06-06 1994-06-06 Tranquilizing agent

Publications (1)

Publication Number Publication Date
RU94020847A true RU94020847A (en) 1997-04-10

Family

ID=48432124

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94020847/14A RU94020847A (en) 1994-06-06 1994-06-06 Tranquilizing agent

Country Status (1)

Country Link
RU (1) RU94020847A (en)

Similar Documents

Publication Publication Date Title
Johnson et al. Diagnosis and treatment of acute urinary tract infections
ES2144516T3 (en) PREPARATION WITH CONTROLLED RELEASE CONTAINING A MORPHINE SALT.
SE9401406D0 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
BR9406893A (en) Use of ninth- and decapeptides for the preparation of a medicine to fight AIDS
RU94027680A (en) Parathyroid hormone and raloxifen for bone mass increase, pharmaceutical composition and method of osseous mass increase
NO923859L (en) DRUG
RU95101385A (en) Products containing g-csf and tnf-binding protein
UA32457C2 (en) Drug (variants) and methods for exposure to drug
RU94020847A (en) Tranquilizing agent
RU94032792A (en) Application of 5htia-antagonists for tobacco use stopping
EA199800770A1 (en) DRUGS FOR THERAPEUTIC TREATMENT OF VIRAL HEPATITIS
RU96102209A (en) MEDICINE
FR2786699B1 (en) MEDICINE, IN PARTICULAR FOR PREVENTING OR TREATING SEXUAL DYSFUNCTIONS
RU94000695A (en) Agent showing antiallergic action
RU94016144A (en) Agent for treatment patient with reiter's disease
RU94019564A (en) Method of gastroenteric diseases treatment
Scrimgeour Do-it-yourself information notes for AIDS counselling in developing countries
何金森 et al. COMPARATIVE ANALYSIS OF THERAPEUTIC EFFECTS OF ACUPUNCTURE IN THE TREATMENT OF HYPERTHYROIDISM
RU2002129102A (en) TREATMENT OF SEPARATE DOSES OF AGENTS WITH VASCULAR DESTRUCTIVE ACTIVITY
RU95102712A (en) Liposome pharmaceutical preparation and curative-prophylaxis cream based on thereof
RU95100741A (en) Method of lung tuberculosis treatment
MD1469G2 (en) Method of treatment of the burn shock
葛通远 et al. AN APPROACH TO THE MECHANISMS OF LASER ACUPUNCTURE IN TREATMENT OF EXOPHTHALMIC HYPERTHYROIDISM
RU97110383A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
RU95105084A (en) Natural hepatoprotective agent